Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid

Experimental Dermatology

Volumn 16, Issue 1, 2007, Pages 13-21

  Rensing ehl, Anne ^a   Gaus, Barbara ^a   Bruckner tuderman, Leena ^a   Martin, Stefan F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Autoimmunity; Blistering disease; Homing; Immune regulation; Skin

Indexed keywords

LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLISTER; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; PEMPHIGOID; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SKIN DEFECT;

AGED; AGED, 80 AND OVER; ANTIGENS, CD4; ANTIGENS, NEOPLASM; AUTOIMMUNITY; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEMPHIGOID, BULLOUS; T-LYMPHOCYTES, REGULATORY;

EID: 33845436688     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00522.x     Document Type: Article

References (54)

1. Giudice G J, Emery D J, Diaz L A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992: 99: 243-250.
2. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 2000: 122: 91-100.
3. Hertl M, Schuler G. Bullous autoimmune dermatoses. 3: Diagnosis and therapy. Hautarzt 2002: 53: 352-365.
4. Schumann H, Baetge J, Tasanen K et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000: 156: 685-695.
5. Hofmann S, Thoma-Uszynski S, Hunziker T et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002: 119: 1065-1073.
6. Franzke C W, Tasanen K, Schumann H, Bruckner-Tuderman L. Collagenous transmembrane proteins: Collagen XVII as a prototype. Matrix Biol 2003: 22: 299-309.
7. Franzke C W, Bruckner P, Bruckner-Tuderman L. Collagenous transmembrane proteins: Recent insights into biology and pathology. J Biol Chem 2005: 280: 4005-4008.
8. Liu Z, Diaz L A, Troy J L et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993: 92: 2480-2488.
9. Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998: 102: 2082-2089.
10. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000: 101: 455-458.
11. Shevach E M, McHugh R S, Piccirillo C A, Thornton A M. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001: 182: 58-67.
12. Shevach E M. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002: 2: 389-400.
13. Bennett C L, Christie J, Ramsdell F et. al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001: 27: 20-21.
14. Wildin R S, Smyk-Pearson S, Filipovich A H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002: 39: 537-545.
15. Yagi H, Nomura T, Nakamura K et. al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004: 16: 1643-1656.
16. Fontenot J D, Rasmussen J P, Williams L M, Dooley J L, Farr A G, Rudensky A Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005: 22: 329-341.
17. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. In vitro generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 2005: 12: 1294-1304.
18. Gambineri E, Torgerson T R, Ochs H D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003: 15: 430-435.
19. Blair P J, Bultman S J, Haas J C, Rouse B T, Wilkinson J E, Godfrey V L. CD4+CD8-T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994: 153: 3764-3774.
20. Godfrey V L, Rouse B T, Wilkinson J E. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol 1994: 145: 281-286.
21. Fields M L, Hondowicz B D, Metzgar M H et. al. CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J Immunol 2005: 175: 4255-4264.
22. Lim H W, Hillsamer P, Banham A H, Kim C H. Cutting edge: Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 2005: 175: 4180-4183.
23. Ehrenstein M R, Evans J G, Singh A et. al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004: 200: 277-285.
24. Kriegel M A, Lohmann T, Gabler C, Blank N, Kalden J R, Lorenz H M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004: 199: 1285-1291.
25. Liu M F, Wang C R, Fung L L, Wu C R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004: 59: 198-202.
26. Viglietta V, Baecher-Allan C, Weiner H L, Hafler D A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004: 199: 971-979.
27. Lindley S, Dayan C M, Bishop A, Roep B O, Peakman M, Tree T I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005: 54: 92-99.
28. Miyara M, Amoura Z, Parizot C et. al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005: 175: 8392-8400.
29. Sugiyama H, Gyulai R, Toichi E et. al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005: 174: 164-173.
30. Gammon W R, Fine J D, Forbes M, Briggaman R A. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992: 27: 79-87.
31. Haase C, Budinger L, Borradori L et. al. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998: 110: 282-286.
32. Roncador G, Brown P J, Maestre L et. al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005: 35: 1681-1691.
33. Baecher-Allan C, Brown J A, Freeman G J, Hafler D A. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001: 167: 1245-1253.
34. Huehn J, Hamann A. Homing to suppress: Address codes for Treg migration. Trends Immunol 2005: 26: 632-636.
35. Jonuleit H, Schmitt E. The regulatory T cell family: Distinct subsets and their interrelations. J Immunol 2003: 171: 6323-6327.
36. Ziegler S F. FOXP3: Of Mice and Men. Annu Rev Immunol 2006: 24: 209-226.
37. Walker M R, Kasprowicz D J, Gersuk V H et. al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003: 112: 1437-1443.
38. Gavin M A, Torgerson T R, Houston E et. al. Single cell analysis of normal and FOXP3 mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006: 103: 6659-6664.
39. Liu W, Putnam A L, Xu-Yu Z et. al. CD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006: 203: 1701-1711.
40. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003: 171: 5760-5768.
41. Siegmund K, Feuerer M, Siewert C et. al. Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005: 106: 3097-3104.
42. Fuhlbrigge R C, Kieffer J D, Armerding D, Kupper T S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997: 389: 978-981.
43. Colantonio L, Iellem A, Sinigaglia F, D'Ambrosio D. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 2002: 32: 3506-3514.
44. Iellem A, Colantonio L, D'Ambrosio D. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur J Immunol 2003: 33: 1488-1496.
45. Dudda J C, Simon J C, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: Role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004: 172: 857-863.
46. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001: 193: 1303-1310.
47. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk A H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001: 193: 1285-1294.
48. Dieckmann D, Plottner H, Dotterweich S, Schuler G. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells. Immunology 2005: 115: 305-314.
49. Thoma-Uszynski S, Uter W, Schwietzke S, Schuler G, Borradori L, Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006: 176: 2015-2023.
50. Weiner H L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001: 182: 207-214.
51. Groux H, O'Garra A, Bigler M et. al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997: 389: 737-742.
52. Veldman C, Hohne A, Dieckmann D, Schuler G, Hertl M. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 2004: 172: 6468-6475.
53. Tang Q, Henriksen K J, Bi M et. al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004: 199: 1455-1465.
54. Tarbell K V, Yamazaki S, Olson K, Toy P, Steinman R M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004: 199: 1467-1477.